Admera Health is an advanced molecular diagnostics company focused on personalized medicine and non-invasive cancer testing. We are committed to improving the health and well-being of our global community. Using next generation genomics and proteomics technologies, Admera Health is redefining the standard of care for patients in all fields of medicine.
Developing tests covering prominent diseases that span the continuum of care. Current products include PGxOne™ Plus for drug response, a Cardiovascular Test Portfolio, and an Oncology Test Portfolio.
Our new product pipeline significantly advances personalized medicine by applying next generation technologies to non-invasive cancer testing and digital health. Keep checking back here periodically as we are continuously updating content and product information.